Skip to main content Accessibility help
×
Home

Infection and premature rupture of the membranes

  • Kyung Seo (a1), James A McGregor (a1) and Janice I French (a1)

Premature rupture of the membranes (prom) and preterm birth

Preterm birth remains a paramount problem in health care worldwide. In the USA, approximately 6–10% of births occur preterm.1–3 Gestational age at birth is the most important determinant of an infant's morbidity and mortality. Preterm infants account for approximately 75% of neonatal deaths,3–5 as well as incalculable direct and indirect financial costs and morbidity.6–9

Copyright

Corresponding author

Kyung Seo, Department of Obstetrics and Gynecology, University of Colorado Health Science Center, Denver, Colorado, USA.

References

Hide All
1Seigel, DG, Stanly, F. Statistics on perinatal morbidity and mortality. In: Quilligan, EJ, Kretchmer, N eds, Fetal and maternal medicine, New York: John Wiley, 1980; 3.
2Gunn, GC, Mishell, DR. Morton, DG. Premature rupture of the fetal membranes. Am J Obstet Gynecol 1970; 106: 469.
3McCormick, MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985; 312: 82.
4Naeye, RL. Causes of perinatal mortality in the US. Collaborative Perinatal Project. JAMA 1977; 238: 228.
5Rush, RW, Keirse, MJNC. Howard, P et al. Contribution of preterm delivery to perinatal mortality. Br Med J 1976; 2: 965.
6Konte, JM, Holbrook, RH Jnr, Larson, RK Jnr, Creasy, RK. Short-term neonatal morbidity associated with preterm birth and effect of a preterm birth prevention program on an expected incidence of morbidity. Am J Perinatol 1986; 3: 283.
7Fitzhardinge, PM. Early growth and development in low birth weight infants following treatment in an intensive care nursery. Pediatrics 1975; 56: 162.
8Allen, MC, Jones, MD. Medical complications of prematurity. Obstet Gynecol 1986; 67: 427.
9Hernandez, JA, Offtt, J, Butterfield, LJ. The cost of care of the less-than-1000-gram infant. Clin Perinatol 1986; 13: 461.
10Kaltreider, DF, Kohl, S. Epidemiology of preterm delivery. Clin Obstet Gynecol 1980; 23: 17.
11Naeye, RL, Peters, EC. Causes and consequences of premature rupture of fetal membranes. Lancet 1980; 1: 192.
12Minkoff, H. Prematurity: infection as an etiologic factor. Obstet Gynecol 1983; 62: 137.
13Miller, JM, Pastorek, JG. The microbiology of premature rupture of the membranes. Clin Obstet Gynecol 1986; 29: 739.
14Alger, LS, Pupkin, MJ. Etiology of preterm premature rupture of the membranes. Clin Obstet Gynecol 1986; 29: 758.
15Lonkey, NM, Hayashi, RH. A proposed mechanism of premature rupture of membranes. Obstet Gynecol Surv 1988; 43: 22.
16McGregor, JA. Preventing preterm birth caused by infection. Contemp Obstet Gynecol 1987; 29(4), 33.
17McGregor, JA. Prevention of preterm birth: New initiatives based on microbial-host interactions. Obstet Gynecol Surv 1988; 43: 1.
18Romero, R, Major, M. Infection and preterm labour. Clin Obstet Gynecol 1988; 31: 553.
19Romero, R, Quintero, R. Oyarzum E et al. Intraamniotic infection and the onset of labour in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988; 159: 661.
20Naeye, RL. Factors that predispose to premature rupture of the fetal membranes. Obstet Gynecol 1982; 60: 93.
21Eggers, TR, Doyle, LW. Pepperell, RJ. Premature rupture of the membranes. Med J Aust 1979; 1: 209.
22Evaldson, G, Lagrelius, A, Winiarski, J. Premature rupture of the membranes. Acta Obstet Gynecol Scand 1980; 59: 385.
23Wideman, GL, Baird, GH. Bolding, OT. Ascorbic acid deficiency and premature rupture of fetal membranes. Am J Obstet Gynecol 1964; 88: 592.
24Artal, R, Burgeson, RE. Fernandez, FJ, Hobel, CJ. Fetal and maternal copper levels in patients at term with and without premature rupture of membranes. Obstet Gynecol 1979; 53: 5.
25Schlievert, P, Johnson, W. Galask, RP. Bacterial growth inhibition by amniotic fluid. V. Phosphate-to-zinc ratio as a predictor of bacterial growth-inhibitory activity. Am J Obstet Gynecol 1976; 125: 899.
26Kiiholma, P, Grönroos, M, Erkkola, R et al. The role of calcium, copper, iron and zinc in preterm delivery and premature rupture of fetal membranes. Gynecol Obstet Invest 1984; 17: 194.
27Naeye, RL, Ross, S. Coitus and chorioamnionitis: a prospective study. Early Hum Dev 1982; 6: 91.
28Polansky, GH, Varner, MW. O'Gorman, T. Premature rupture of the membranes and barometric pressure changes. Lancet 1978; 1: 189.
29Naeye, RL, Blanc, WA. Relation of poverty and race to antenatal infection. N Engl J Med 1970; 283: 555.
30Hardy, PH, Hardy, JB. Nell, EE et al. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 1984; 2: 333.
31Naeye, RL. Seasonal variations in coitus and other risk factors, and the outcome of pregnancy. Early Hum Dev 1980; 4: 61.
32Daikoku, NH, Kaltreider, F. Khouzami, VA et al. Premature rupture of the membrane and spontaneous preterm labour: maternal endometritis risks. Obstet Gynecol 1982; 59: 13.
33Dodds, WG, Iams, JD. Maternal C-reactive protein and preterm labour. J Reprod Med 1987; 32: 527.
34Handwerker, SM, Tejani, NA. Verma, UL et al. Correlation of maternal serum C-reactive protein with outcome of tocolysis. Obstet Gynecol 1984; 63: 220.
35Hawrylyshyn, P, Bernstein, P. Milligan, JE et al. Premature rupture of the membranes: the role of C-reactive protein in the prediction of chorioamnionitis. Am J Obstet Gynecol 1983; 147: 240.
36Evans, MI, Hajj, SN. Devoe, LD et al. C- reactive protein as a predictor of infection morbidity with premature rupture of the membranes. Am J Obstet Gynecol 1980; 138: 648.
37Buetow, KC, Klein, SW. Lane, RB. Septicemia in premature infants Am J Dis Child 1965; 110: 29.
38Daikoku, NH, Kaltreider, F. Johnson, TRB et al. Premature rupture of the membrane and preterm labour: neonatal infection and perinatal mortality risks. Obstet Gynecol 1981; 58: 417.
39Cederqvist, LL, Zervoudakis, IA. Ewool, LC, Litwin, SD. The relationship between prematurely ruptured membranes and fetal immunoglobulin production. Am J Obstet Gynecol 1979; 134: 784.
40Guzick, DS, Winn, K. The association of chorioamnionitis and preterm delivery. Obstet Gynecol 1985; 65: 11.
41Chellam, VG, Rushton, DI. Chorioamnionitis and funiculitis in the placenta of 200 births weighing less than 2.5 kg. Br J Obstet Gynaecol 1985; 92: 808.
42Pankuch, GA, Appelbaum, PC. Lorenz, RP et al. Placental microbiology and histology and the pathogenesis of chorioamnionitis. Obstet Gynecol 1984; 64: 802.
43Hillier, SH, Martius, J. Krohn, M et al. A casecontrol study of chorioamniotic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319: 972.
44Miller, JM, Hill, GB. Welt, SI, Pupkin, MJ. Bacterial colonization of amniotic fluid in the presence of ruptured membranes. Am J Obstet Gynecol 1980; 137: 451.
45Knox, IC. The role of infection in premature rupture of the membrane. Am J Obstet Gynecol 1950; 59: 190.
46Creatsas, G, Pavlatos, M. Lolis, D et al. Bacterial contamination of the cervix and premature rupture of membranes. Am J Obstet Gynecol 1981; 139: 522.
47Minkoff, HL, Grunebaum, AN. Schwarz, RH et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984; 150: 965.
48McGregor, JA, French, JI. Richter, R et al. Cervico-vaginal microbial-host interaction and maternal and perinatal outcomes: refining the hypothesis. Abstract #63, Society for Gynecologic Investigation Scientific Program and Abstracts, Baltimore, Maryland, March 17–20, 1988: 91.
49Amstey, MS, Steadman, KY. Asymptomatic gonorrhea and pregnancy. J Am Vener Dis Assoc 1976; 3: 14.
50Regan, JA, Chao, S. James, LS. Premature rupture of the membranes, preterm delivery, and group B streptococcal colonization of mothers. Am J Obstet Gynecol 1981; 141: 184.
51Martin, DH, Koutsky, L. Eschenbach, DA et al. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA 1982; 247: 1585.
52Harrison, HR, Alexander, ER. Weinstein, L et al. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA 1983; 250: 1721.
53Gravett, MG, Nelson, HP. DeRouen, T et al. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256: 1899.
54Braun, P, Lee, Y-H, Klein, JO et al. Birthweight and genital mycoplasmas in pregnancy. N Engl J Med 1971; 284: 167.
55Kundsin, RB, Driscoll, SG. Monson, RR et al. Association of ureaplasma urealyticum in the placenta with perinatal morbidity and mortality. N Engl J Med 1984; 310: 941.
56Gravett, MG, Hummel, D. Eschenbach, DA et al. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986; 67: 229.
57Miller, JM, Pupkin, MJ. Hill, GB. Bacterial colonization of amniotic fluid from intact fetal membranes. Am J Obstet Gynecol 1980; 136: 796.
58Bobitt, JR, Ledger, WJ. Unrecognized amnionitis and prematurity. A preliminary report. J Reprod Med 1977; 19: 8.
59Hameed, C, Tejani, N. Verma, UL et al. Silent chorioamnionitis as a cause of preterm labor refractory to tocolytic therapy. Obstet Gynecol 1984; 149: 726.
60Plaut, AG. Microbial IgA proteases. N Engl J Med 1978; 298: 1459.
61 Kapatais-Zoumbos, K, Chandler, DKF. Bariie, MF. Survey of immunoglobulin A protease activity among selected species of Ureaplasma and Mycoplasma: specificity for host immunoglobulin A. Infect Immun 1985; 47: 404.
62McGregor, JA, Lawellin, D. Schroeter, U et al. IGG protease activity in microorganisms associated with upper genital tract infection determined by ELISA. Abstracts #157P, Society for Gynecologic Investigation Scientific Program and Abstracts, Toronto, Ontario, Canada, March 19–22, 1986: 111.
63McGregor, JA, Lawellin, D. Franco-Buff, A et al. Mucinase (neuraminidase) production in microorganisms associated with upper genital tract infection. Abstracts #159P, Society for Gynecologic Investigation Scientific Program and Abstracts, Toronto, Ontario, Canada, March 19–22, 1986: 112.
64Galask, RP, Snyder, IS. Bacterial inhibition by amniotic fluid. Am J Obstet Gynecol 1968; 102: 949.
65Bergman, N, Bercovici, B. Sacks, T. Antibacterial activity of human amniotic fluid. Am J Obstet Gynecol 1972; 114: 520.
66Larsen, B, Snyder, IS. Galask, RP. Bacterial growth inhibition by amniotic fluid. I. In vitro evidence for bacterial growth inhibitory activity. Am J Obstet Gynecol 1974, 119: 492.
67Thadepalli, H, Bach, T. Davidson, EC. Antimicrobial effect of amniotic fluid. Obstet Gynecol 1978; 52: 198.
68Schlievert, P, Larsen, B. Johnson, W et al. Bacterial growth inhibition by amniotic fluid. III. Demonstration of the variability of bacterial growth inhibition by amniotic fluid with a new plate-count technique. Am' J Obstet Gynecol 1975; 122: 809.
69Cherry, SH, Filler, M. Harvey, H. Lysozyme content of amniotic fluid. Am J Obstet Gynecol 1973; 116: 639.
70Gusdon, JP. A bactericidin present for Bacillus subtilis in pregnancy. J Immunol 1962; 88: 494.
71Usategui-Gomez, J, Morgan, DF. Toolan, HW. A comparative study of amniotic fluid, maternal serum, and cord sera by disc electrophoresis. Proc Soc Exp Biol Med 1966; 123: 547.
72Larsen, B, Snyder, IS. Galask, RP. Transferrin concentration in human amniotic fluid. Am J Obstet Gynecol 1973; 117: 952.
73Thadepalli, H, Gangopadhyay, PK. Maidman, JE. Amniotic fluid analysis for antimicrobial factors. Int J Gynaecol Obstet 1982; 20: 65.
74Larsen, B, Galask, RP, Snyder, IS. Muramidase and peroxidase activity of human amniotic fluid. Obstet Gynecol 1974; 44: 219.
75Schlievert, P, Johnson, W. Galask, RP. Amniotic fluid antibacterial mechanism: newer concepts. Semin Perinatol 1977; 1: 59.
76Gonik, B, Bottoms, SF. Cotton, DB. Amniotic fluid volume as a risk factor in preterm premature rupture of the membranes. Obstet Gynecol 1985; 65: 456.
77Blanco, JD, Gibbs, RS, Krebs, LK, Castaneda, YS. The association between the absence of amniotic fluid inhibitory activity and intraamniotic infection. Am J Obstet Gynecol 1982; 143: 749.
78Nazir, MA, Pankach, GA. Botti, JJ et al. Antibacterial activity of amniotic fluid in the early third trimester. Am J Perinatol 1987; 4: 59.
79MacDonald, PC, Porter, JC. Schwarz, BE et al. Initiation of parturition in human female. Sem Perinatol 1978; 2: 273.
80Bennet, PR, Elder, MG, Myatt, L. The effect of lipoxygenase metabolites of arachidonic acid on human myometrial contractility. Prostaglandins 1987; 33: 837.
81Bejar, R, Curbelo, V, Davis, C, Gluck, L. Premature labor: bacterial sources of phospholipase. Obstet Gynecol 1981; 57: 479.
82McGregor, JA, Lawellin, D, Franco-Buff, A et al. Phospholipase A2 activity of genital tract microflora detected with two substrates. Abstracts #153, Society for Gynecologic Investigation Scientific Program and Abstracts, Phoenix, Arizona, 03 2023, 1985.
83McGregor, JA, Lawellin, D, Franco-Buff, A et al. Phospholipase C production by microorganisms associated with female upper genital tract infections. Abstracts #362P, Society for Gynecologic Investigation Scientific Progam and Abstracts, Phoenix, Arizona, 03 2023, 1985: 208.
84Lamon, RF, Rose, M, Elder, MG. Effects of bacterial products on prostaglandin E production by amnion cells. Lancet 1985; 2: 1131.
85Bennet, PR, Rose, MP, Myatt, L. Preterm labor: stimulation of arachidonic acid metabolism in human amnion by bacterial products. Am J Obstet Gynecol 1987; 156: 649.
86McGregor, JA. Microorganisms and arachidonic acid metabolites in preterm birth. Semin Reprod Endocrinol 1985; 3: 273.
87McGregor, JA, Todd, J, Lawellin, D et al. The formation of arachidonic acid metabolites by cervical/vaginal microorganisms. Abstracts #28P, Society for Gynecologic Investigation Scientific Program and Abstracts, Phoenix, Arizona, 03 2023, 1985: 17.
88Lawellin, D, Kishiyama, J, Carson, J et al. Formation of arachidonic acid metabolites by cervical/vaginal microorganisms. Society for Gynecologic Investigation Scientific Program and Abstracts, Phoenix, Arizona, 03 2023, 1985: 20.
89Ban, C, Billah, MM, Truong, CT, Johnston, JM, Metabolism of platelet activating factor in human fetal membranes and decidua vera. Arch Biochem Biophys 1986; 246: 9.
90 O'Flaherty, JT, Wykle, R. Biology and biochemistry of platelet activating factor. Clin Rev Allergy 1983; 1: 353.
91Nishihira, J, Ishibashi, T, Imai, Y, Muramatsu, T. Mass spectrometric evidence for the presence of platelet-activating factor in human amniotic fluid during labor. Lipids 1984; 19: 907.
92Huang, K, Wallner, BP, Mattaliano, RJ et al. Two human 35 KD inhibitors of phospholipase A2 are related to substrates of pp60 v-src and of the epidermal growth factor/kinase. Cell 1986; 46: 191.
93Kurland, JI, Bockman, R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med 1978; 147: 952.
94Romero, R, Hobbins, JC. Mitchell, MD. Endotoxin stimulates prostaglandin E2 production by human amnion. Obstet Gynecol 1988; 71: 227.
95Romero, R, Kadar, N, Hobbins, JC, Duff, GW. Infection and labor: the detection of endotoxin in amniotic fluid. Am J Obstet Gynecol 1987; 157: 815.
96Romero, R, Roslansky, P, Oyarzum, E et al. Labor and infection II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor. Am J Obstet Gynecol 1988; 158: 1044.
97Nathan, CF. Secretory products of macrophage. J Clin Invest 1987; 79: 319.
98Dinarello, CA. Interleukin-1. Rev Infect Dis 1984; 6: 51.
99Mitzel, SB, Dayer, JM, Krane, SM et al. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte activating factor (interleukin 1). Proc Natl Acad Sci USA 1981; 78: 2474.
100Jyonouchi, H, Voss, RM, Good, KA. IL 1-like activities present in murine amniotic fluid. A significantly larger amount of IL 1 beta-like activity is present in the amniotic fluid of autoimmune NZB mice. J Immunol 1987; 138: 3300.
101Ito, A, Hiro, D, Ojima, Y et al. Spontaneous production of interleukin-1-like factors from pregnant rabbit uterine cervix. Am J Obstet Gynecol 1988; 159: 261.
102Romero, R, Brody, DT, Oyarzum, E et al. Infection and labor III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989; 160: 1117.
103Beutler, B, Creami, A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379.
104Jaattella, M, Kuusela, P. Saksela, E. Demonstration of tumor necrosis factor in human amniotic fluid and supernatants of placental and decidual tissue. Lab Invest 1988; 58: 48.
105Romero, R, Manogue, K, Wu, YK et al. Tumor necrosis factor. A signal for the initiation of labor in chorioamnionitis. Abstract presented at the 8th Annual Meeting of the Society of Perinatal Obstetricians.Las Vegas,1988.
106Kent, J, Witkin, S, Druzin, M. Elevated levels of IL2 receptor as a serologic marker for preterm birth in women with preterm labor. Society for Gynecologic Investigation Scientific Program and Abstracts 1988: 100.
107Bartocci, A, Pollard, JW, Stanley, ER. Regulation of colony-stimulating factor 1 during pregnancy. J Exp Med 1986; 164: 956.
108Ringler, GE, Coutifaris, C, Strauss, JF et al. Accumulation of colony-stimulating factor 1 in amniotic fluid during pregnancy. Am J Obstet Gynecol 1989; 160: 655.
109Artal, R, Burgeson, RE, Hobel, CJ et al. An in vitro model for the study of enzymatically mediated biomechanical changes in the chorioamniotic mebrane. Am J Obstet Gynecol 1979; 133: 656.
110McGregor, JA, Schoonmaker, JN, French, JI et al. Impairment of amniochorion strength, elasticity and work to rupture by neutrophils, lymphocytes, and leukocyte elastase. Abstract #25, Society for Gynecologic Investigation Scientific Program and Abstracts, Baltimore, Maryland, 03 1720, 1988: 72.
111McGregor, JA. Unpublished data.
112McGregor, JA, Lawellin, D, Franco-Buff, A.. Protease production by microorganisms associated with reproductive tract infection. Am J Obstet Gynecol 1986; 154: 109.
113McGregor, JA, French, JI. Lawellin, D et al. In vitro study of bacterial protease-induced reduction of chorioamniotic membrane strength and elasticity. Obstet Gynecol 1987; 69: 167.
114Skinner, SJM, Campos, GA. Liggins, GC. Collagen content of human amniotic membranes: effect of gestation length and premature rupture. Obstet Gynecol 1981; 57: 487.
115Kanayama, N, Terao, T. Kawashima, Y et al. Collagen types in normal and prematurely ruptured amniotic membranes. Am J Obstet Gynecol 1985; 153: 899.
116Mainardi, CL, Hasty, DL. Seyer, JM et al. Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem 1980; 255: 12006.
117Warwas, M, Dobryszycka, W. Cathepsin B1 from human fetal membranes. Biochem Biophys Acta 1976; 429: 573.
118Burgos, H, Hsi, BL, Yeh, CJG, Faulk, WP. Plasminogen binding by human amniochorion: a possible factor in premature rupture of the membranes. Am J Obstet Gynecol 1982; 143: 958.
119Jenkins, DM, France, VM, Hsi, B, Faulk, WP. Degenerative changes and detection of plasminogen in fetal membranes that rupture prematurely. Br J Obstet Gynaecol 1983; 90: 841.
120Kanayama, N, Kamijo, H. Tera, T et al. The relationship between trypsin activity in amniotic fluid and premature rupture of membranes. Am J Obstet Gynecol 1986; 155: 1043.
121Milwidsky, A, Hurwitz, A. Eckstein, L et al. Proteolytic enzymes in human fetal membranes and amniotic fluid. A comparison of normal and premature ruptured membranes. Enzyme 1985; 33: 188.
122Sutcliffe, RG, Brock, DJN. Immunological studies on the nature and origin of the major proteins in amniotic fluid. J Obstet Gynaecol Br Commonw 1973; 80: 721.
123Gibaud, S, Bonnet, M, Thoulon, JM, Dumont, M. Alpha 1-antitrypsin in amniotic fluid. Obstet Gynecol 1975; 45: 34.
124Bhat, AR, Issac, V, Pattabiraman, TN. Protease inhibitors in serum and amniotic fluid during pregnancy. Br J Obstet Gynaecol 1979; 86: 222.
125Burnett, D, Bradwell, AR. The origin of plasma proteins in human amniotic fluid. The significance of alpha 1-antichymotrypsin complexes. Biol Neonate 1980; 37: 302.
126Bhat, AR, Pattabiraman, TN. Urinary proteinase inhibitor in premature infants and its comparison with amniotic-fluid acid-stable proteinase inhibitor. Biochem Med 1982; 27: 168.
127Stricklin, GP, Gast, MJ. Welgus, HG. Amniotic fluid collagenase inhibitor: correlation with gestational age and fetal lung maturity. Am J Obstet Gynecol 1986; 154: 134.
128Sbarra, AJ, Selvaraj, RJ, Cetrulo, CL et al. Infection and phagocytosis as possible mechanism of rupture in premature rupture of the membrane. Am J Obstet Gynecol 1985; 153: 38.
129Sbarra, AJ, Thomas, GB. Cetrulo, CL. Effect of bacterial growth on the bursting pressure of fetal membrane in vitro. Obstet Gynecol 1987; 70: 107.
130Elder, HA, Santamarina, BAG, Smith, S et al. The effect of tetracycline on the clinical course and the outcome of pregnancy. Am J Obstet Gynecol 1971; 111: 441.
131McGregor, JA, French, JI, Reller, B et al. Adjunctive erythromycin treatment for idiopathic preterm labor: result of a randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1986; 154: 98.
132Thomsen, AC, Morup, L, Hansen, KB. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labor. Lancet 1987; 1: 591.
133McGregor, JA, French, JI, Richter, R et al. Prospective, double-blinded, randomized, placebo-controlled trial of short-course erythromycin base in women at high risk for preterm birth. Abstract #62, Society for Gynecologic Investigation Scientific Program and Abstracts, Baltimore, Maryland, 03 17–20, 1988: 90.
134Blackmon, LR, Alger, LS, Crenshaw, C. Fetal and neonatal outcomes associated with premature rupture of the membranes. Clin Obstet Gynecol 1986; 29: 779.
135Garite, TJ, Freeman, RK. Chorioamnionitis in the preterm gestation. Obstet Gynecol 1982; 54: 539.
136Varner, MW, Galask, RP. Conservative management of premature rupture of the membranes. Am J Obstet Gynecol 1981; 140: 39.
137Schreiber, J, Benedetti, T. Conservative management of preterm premature rupture of the fetal membranes in a low socioeconomic population. Am J Obstet Gynecol 1980; 136: 92.
138Yoder, PR, Gibbs, RS, Blanco, JD et al. A prospective, controlled study of maternal and perinatal outcome after intraamniotic infection at term. Am J Obstet Gynecol 1983; 145: 695.
139Wilson, JC, Levy, DC, Wilds, PL. Premature rupture of membranes prior to term: consequences of non-intervention. Obstet Gynecol 1982; 60: 601.
140Berkowitz, RL, Hoder, L, Freeman, RM et al. Results of a management protocol for premature rupture of the membranes. Obstet Gynecol 1982; 60: 271.
141 StGeme, JW. Perinatal and neonatal infections. West J Med 1975; 122: 359.
142 StGeme, JW, Murray, DL, Carter, J et al. Perinatal bacterial infection after prolonged rupture of amniotic membranes: an analysis of risk and management. J Pediatr 1984; 104: 608.
143Graham, RL, Gilstrap, LC, Hauth, JC et al. Conservative management of premature rupture of fetal membranes. Obstet Gynecol 1982; 59: 607.
144Bada, HS, Alojipan, LC, Andrews, BF. Premature rupture of membranes and its effect on the newborn. Pediatr Clin North Am 1977; 24: 491.
145Brame, RG, MacKenna, J. Vaginal pool phospholipids in management of premature rupture of membranes. Am J Obstet Gynecol 1983; 145: 992.
146Garite, TJ, Freeman, RK, Linzey, EM et al. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. Am J Obstet Gynecol 1981; 141: 508.
147Thibeault, DW, Emmanouilides, GC. Prolonged rupture of fetal membranes and decreased frequency of respiratory distress syndrome and patent ductus arteriosus in preterm infants. Am J Obstet Gynecol 1977; 129: 43.
148Fayez, JA, Hasan, AA, Jonas, HS et al. Management of premature rupture of the membranes. Obstet Gynecol 1978; 52: 17.
149Buemann, B, Lange, P. Premature rupture of the membranes at fetal weights of 1000 to 2500 g. Acta Obstet Gynecol Scand 1962; 41: 346.
150Johnson, JWC, Daikoku, NH, Niebyl, JR et al. Premature rupture of the membranes and prolonged latency. Obstet Gynecol 1981; 57: 547.
151Schutte, MF, Treffers, PE, Kloosterman, GJ, Soepatoni, S. Management of premature rupture of membranes: the risk of vaginal examination to the infant. Am J Obstet Gynecol 1978; 61: 171.
152Gibbs, RS. Diagnosis of intra-amniotic infection. Semin Perinatol 1977; 1: 71.
153Romen, Y, Artal, R. C-reactive protein as a predictor for chorioamnionitis in cases of premature rupture of the membranes. Am J Obstet Gynecol 1984; 150: 546.
154Ismail, MA, Zinaman, MJ, Lowensohn, RI, Moaward, AH. The significance of C-reactive protein levels in women with premature rupture of membranes. Am J Obstet Gynecol 1985; 151: 541.
155Farb, HF, Arnesser, M, Geistler, P, Knox, GE. C-reactive protein with premature rupture of membranes and premature labor. Obstet Gynecol 1983; 62: 49.
156Levy, DL, Arguembourg, PC. Maternal and blood complement activity: relationship to premature rupture of the membranes. Am J Obstet Gynecol 1981; 139: 38.
157Vintzileos, AM, Campbell, WA, Nochimson, DJ et al. Fetal biophysical profile versus amniocentesis in predicting infection in preterm premature rupture of the membranes. Obstet Gynecol 1986; 68: 488.
158Goldstein, I, Romero, R, Merrill, S et al. Fetal body and breathing movements as predictors of intraamniotic infection in preterm premature rupture of membranes. Am J Obstet Gynecol 1988; 159: 363.
159Larsen, J, Weis, K, Leniham, J et al. Significance of neutrophils and bacteria in the amniotic fluid of patients in labor. Obstet Gynecol 1976; 47: 143.
160Gibbs, RS, Blanco, JD, StClair, PJ, Castenada, YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis 1982; 145: 1.
161Listwa, HM, Dobek, AS, Carpenter, J, Gibbs, RS. Predictability of intrauterine infection by analysis of amniotic fluid. Obstet Gynecol 1976; 48: 31.
162Romero, R, Emamian, M, Quintero, R et al. The value and limitations of the gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol 1988; 159: 114.
163Gravett, MG, Eschenbach, DA, Spiegel-Brown, CA, Holmes, KK. Rapid diagnosis of amniotic fluid infection by gas liquid chromatography. N Engl J Med 1982; 306: 725.
164Garite, TJ, Freeman, RK, Linzey, EH, Braley, P. The use of amniocentesis in patients with premature rupture of membranes. Obstet Gynecol 1979; 54: 226.
165Zlatnick, FJ, Cruikshank, DP, Petzold, CR, Galask, RP. Amniocentesis in the identification of inapparent infection in preterm patients with premature rupture of the membranes. J Reprod Med 1984; 29; 656.
166Cotton, DB, Hill, LM, Strassner, HT et al. Use of amniocentesis in preterm gestation with ruptured membranes. Obstet Gynecol 1984; 63: 38.
167Broekhuizen, FF, Gilman, M, Hamilton, PR. Amniocentesis for gram stain and culture in preterm premature rupture of the membranes Obstet Gynecol 1985; 66: 316.
168Vintzileos, AM, Campbell, WA, Nochimson, DJ et al. Qualitative amniotic volume versus amniocentesis in predicting infection in preterm rupture of the membranes. Obstet Gynecol 1986; 67: 579.
169Feinstein, ST, Vintzileos, AM, Lodeiro, JG et al. Amniocentesis with premature rupture of the membranes. Am J Obstet Gynecol 1986; 68: 147.
170Blanco, JD, Gibbs, RS, Krebs, LK. A controlled study of amniotic fluid immunoglobulin levels in intraamniotic infection. Obstet Gynecol 1983; 61: 450.
171Ismail, MA, Yang, S, Abusarif, AN, Moawad, AH. Immunoglobulins in prolonged ruptured membranes. Am J Obstet Gynecol 1985; 153: 390.
172Benirschke, K, Clifford, SH. Intrauterine bacterial infection of the newborn infant – frozen sections of the cord as an aid to early diagnosis. J Pediatr 1959; 54: 11.
173Overbach, AM, Daniel, SJ, Cassady, G. The value of umbilical cord histology in the management of potential perinatal infection. J Pediatr 1970; 76: 22.
174Maudsley, RF, Brix, GA. Hinton, NA et al. Placental inflammation and infection: a prospective bacteriologic and histologic study. Am J Obstet Gynecol 1966; 95: 648.
175Dong, Y, St. Clair, PJ, Ramzy, I et al. A microbiologic and clinical study of placental inflammation at term. Obstet Gynecol 1987; 70: 175.
176Driscoll, SG. Significance of acute chorioamnionitis. Clin Obstet Gynecol 1979; 22: 339.
177Kappy, KA, Certulo, CL, Knuppel, RA et al. Premature rupture of the membranes: a conservative approach. Am J Obstet Gynecol 1979; 134: 655.
178Capeless, EL, Mead, PB. Management of premature rupture of membranes: lack of consensus. Am J Obstet Gynecol 1987; 157: 11.
179Lebherz, TB, Hellman, LP, Madding, R et al. Double-blind study of premature rupture of the membranes. Am J Obstet Gynecol 1963; 87: 218.
180Amon, E, Lewis, SV, Sibbai, BM et al. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol 1988; 159: 539.
181McGregor, JA, French, JI. Double-blind randomized, placebo controlled, prospective evaluation of the efficacy of short course erythromycin in prolonging gestation among women with preterm rupture of membranes. Abstract, Society of Perinatal Obstetricians, 1988.
182Morales, WJ, Angel, JL, O'Brien, WF et al. Use of ampicillin and corticosteroids in premature rupture of membranes: A randomized study. Obstet Gynecol 1989; 73: 721.
183Ogita, S, Mizuno, M, Takeda, Y et al. Clinical effectiveness of a new cervical indwelling catheter in the management of premature rupture of the membranes: a Japanese collaborative study. Am J Obstet Gynecol 1988; 159: 336.
184Iams, JD, Talbert, ML, Barrows, H et al. A prospective randomized comparison of observation versus use of steroids and timed delivery. Am J Obstet Gynecol 1985; 151: 32.
185Kuhn, RJP, Speirs, AL, Pepperell, RJ et al. Betamethasone, albuterol and threatened premature delivery: benefits and risks. Obstet Gynecol 1982; 60: 403.
186Morales, WJ, Diebel, ND, Lazar, AJ et al. The effect of antenatal dexamethasone administration on prevention of respiratory distress syndrome in preterm gestations with premature rupture of the membranes. Am J Obstet Gynecol 1986; 154: 591.
187Nelson, LH, Meis, PJ, Hatjis, CG et al. Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstet Gynecol 1985; 66: 55.
188Schmidt, PL, Sims, ME, Strassner, HT et al. Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. Am J Obstet Gynecol 1984; 148: 178.
189Simpson, GF, Harbert, GH Jnr. Use of betamethasone in management of preterm gestation with premature rupture of membranes. Obstet Gynecol 1985; 66: 168.
190Taeusch, HW, Frigoletto, F, Kitzmiller, J et al. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics 1979; 63: 64.
191Young, BK, Klein, SA, Katz, M et al. Intravenous dexamethasone for prevention of neonatal respiratory distress: a prospective controlled study. Am J Obstet Gynecol 1980; 138: 203.
192Bourgeois, FJ, Harbert, GM, Anderson, WA et al. Early versus late tocolytic treatment for preterm premature membrane rupture. Am J Obstet Gynecol 1988; 159: 742.
193Christensen, KK, Ingemarsson, I, Leideman, T et al. Effects of ritodrine on labor after premature rupture of the membranes. Obstet Gynecol 1987; 157: 388.
194Garite, TJ, Keegan, KA, Freeman, RK et al. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation. Am J Obstet Gynecol 1987; 157: 388.
195Weiner, CP, Renk, K, Klugman, M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol 1988; 159: 216.
196Curet, LB, Rao, AV, Zachman, RD et al. Association between ruptured membranes, tocolytic therapies, and respiratory distress syndrome. Am J Obstet Gynecol 1984; 148: 263.
197McGregor, JA, Schoonmaker, J, Lunt, B et al. Antimicrobial inhibition of bacteria-mediated fetal membrane alterations. Abstract, Infectious Disease Society for Obstetrics – Gynecology, The Crestwood Snowmass Village, Colorado, 08 4–6, 1988.

Infection and premature rupture of the membranes

  • Kyung Seo (a1), James A McGregor (a1) and Janice I French (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed